Ledger.Open graph →
SEC Form D · filed August 25, 2023

Genesis Therapeutics, Inc

Offering
$224.0M
Sold
$224.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BURLINGAME, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Evan Feinberg · Vicente Lopez, Buenos Aires, C1Exec · DirectorLeonard Bell · BURLINGAME, CADirectorBenjamin Sklaroff · BURLINGAME, CAExecPeptiboon Prasit · BURLINGAME, CAExec · DirectorBenjamin Sklaroff · BURLINGAME, CAExecKris Jenner · BURLINGAME, CADirectorKris Jenner · BURLINGAME, CADirectorWilliam Mccarthy · BURLINGAME, CAExecLeonard Bell · BURLINGAME, CADirectorVijay Pande · Santa Barbara, CADirectorEvan Feinberg · Vicente Lopez, Buenos Aires, C1Exec · DirectorVijay Pande · Santa Barbara, CADirectorWilliam Mccarthy · BURLINGAME, CAExecPeptiboon Prasit · BURLINGAME, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗